Hygieia appoints diabetes veteran Doug Lawrence as CEO

[Image from Hygieia]Hygieia — a developer of digital therapeutics for insulin therapy — announced today that it appointed Doug Lawrence as its CEO.

Lawrence will take the corner office at Livonia, Michigan-based Hygieia with responsibilities for leading operations, development, and global growth of the company and its d-Nav insulin management program. The FDA-cleared d-Nav system autonomously adjusts insulin dose recommendations to correspond to a patient’s changing insulin needs.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0